Haemair was founded to develop an enhanced Extracorporeal Life Support (ECLS/ECMO) system to support patients with reversible life threatening respiratory or cardiac disease for periods days to weeks. We sought the best components for complete systems including oxygenators, pumps, and instruments. The technology has underpinned a portfolio of products with applications ranging from organ transplantation to blood transfusion.
Haemair was founded by engineers with close relatives who had suffered and died of lung disease. From the outset, the vision was of a device that would directly oxygenate blood to augment residual lung capacity and ultimately provide an alternative to lung transplant. In developing components for an improved system, the innovations have found a much wider range of applications.
US patent granted for a cell washing apparatus to improve blood transfusions
Publication of study showing that Haemair cell-washing apparatus removes potentially harmful components that accumulate during storage of transfusion blood without damaging red blood cells.
Use of Haemair pulsatile pump for ex-vivo perfusion of porcine kidneys shows improved urine production and reduced resistance to blood flow through compared to use of well-established centrifugal blood pump.
Welcome to Haemair
Developing Life-saving Technology
Our mission – our skills
Haemair has created a range of related technologies built on skills in the physical and chemical properties of blood. All have the objective of saving and improving lives in a cost-effective manner. Our focus is on developing and commercializing these technologies; we are seeking collaborators to work with us in partnerships to take the following products to market:
– a device that improves the quality of stored blood by removing toxic components that accumulate over time
– a low haemolysis pulsatile blood pump for applications including extending the viability of individual organs and in reducing the risks of procedures requiring cardiopulmonary bypass. The pump can mimic the pulse profile found in living beings.
– a novel compact blood oxygenator
– a full system for maintaining organ viability ex-vivo to provide improved organs for transplant or for pharmaceutical testing
– a device for treating the comorbidities of Acute Respiratory Distress Syndrome and Acute Kidney Injury
– extracorporeal Life Support (ECLS)
– control of ECLS systems
Each of these technologies is described under “Products”